Tips and Insights
Here are some tips & insights extracted from CELforPharma’s courses. Some are plain definitions of terms that often cause confusion, others offer invaluable advice for better planning and decision-making. Use the filters to find insights related to your functional area.
Highlights of the 2021 Across Health Maturometer
| Expert: | Jan Keuppens & Vladimir Rogiers |
| Course: | The Strategic Digital Pharma Marketing CourseThe Strategic e-Medical Affairs Course |
Video: What is a QALY and how to calculate it? – By Prof. Dr. Lieven Annemans:
| Expert: | Prof. Dr. Lieven Annemans |
| Course: | Health Economics for Non-Health-EconomistsBasics of Health Economics |
What you should know about RWE:
| Expert: | Dr. Paul Craddy & Dr. Graham Foxon |
| Course: | Generating RWE for Optimising Market Access |
AGILE & CUSTOMER CENTRIC BRAND PLAN QUALITY CHECKLIST
| Expert: | Edouard Demeire |
| Course: | The Pharma Brand Planning Course |
The 5 lessons Pharma should learn from the COVID-19 pandemic
| Expert: | Edouard Demeire |
| Course: | The Pharma Brand Planning Course |
Video: 13 Checkpoints to critically assess the quality of your brand marketing plans
| Expert: | Edouard Demeire |
| Course: | The Pharma Brand Planning Course |
Video: 9,5 steps to a successful Advisory Board Meeting
| Expert: | Maaike Addicks, MD |
| Course: | Business Acumen for MSLs |
Video: The in- & out-licensing processes at a glance
| Expert: | David Scott |
| Course: | The Pharmaceutical Out-licensing Course |
10 Critical success factors for pharma lifecycle management
| Expert: | Dr. Neal Hansen |
| Course: | Late Stage Pharma Lifecycle Management |
2 Videos with Prof. Lieven Annemans explaining fundamental concepts in health economics:
| Expert: | Prof. Dr. Lieven Annemans |
| Course: | Health Economics for Non-Health-Economists |
3 main challenges in pharma forecasting
| Expert: | Gary Johnson & Sam Johnson |
| Course: | The Pharma Forecasting Course |
3 main pharma value pricing challenges
| Expert: | Gary Johnson & Sam Johnson |
| Course: | Value Pricing for Optimising Market Access |
3 main problem areas in pharma business development
| Expert: | Stefan Fischer |
| Course: | The Pharma Business Development Course |
5 Best Practices In Late Lifecycle Management
| Expert: | Dr. Neal Hansen |
| Course: | Late Stage Pharma Lifecycle Management |
9,5 steps to a successful Advisory Board Meeting – Do you actually need one?
| Expert: | Maaike Addicks, MD |
| Course: | Business Acumen for MSLs |
A 5-step process for planning late stage lifecycle management
| Expert: | Dr. Neal Hansen |
| Course: | Late Stage Pharma Lifecycle Management |